Skip to main content
  • AACR Publications
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

  • Register
  • Log in
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Focus on Computer Resources
    • 75th Anniversary
    • Meeting Abstracts
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • OnlineFirst
    • Editors' Picks
    • Citations
    • Author/Keyword
  • News
    • Cancer Discovery News
  • AACR Publications
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in

Search

  • Advanced search
Cancer Research
Cancer Research

Advanced Search

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Focus on Computer Resources
    • 75th Anniversary
    • Meeting Abstracts
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • OnlineFirst
    • Editors' Picks
    • Citations
    • Author/Keyword
  • News
    • Cancer Discovery News
Prevention Research

Abstract 3694: Complex effects of dietary apigenin on prevention of MPA-accelerated DMBA-induced mammary tumors in Sprague-Dawley rats.

Benford Mafuvadze, Matthew Cook, Xu Zhang, Cindy Besch-Williford and Salman M. Hyder
Benford Mafuvadze
1Univ. of Missouri, Columbia, MO;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Matthew Cook
1Univ. of Missouri, Columbia, MO;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xu Zhang
1Univ. of Missouri, Columbia, MO;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Cindy Besch-Williford
2IDEXX RADIL, Columbia, MO.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Salman M. Hyder
1Univ. of Missouri, Columbia, MO;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1158/1538-7445.AM2013-3694 Published April 2013
  • Article
  • Info & Metrics
Loading
Proceedings: AACR 104th Annual Meeting 2013; Apr 6-10, 2013; Washington, DC

Abstract

Epidemiological and laboratory studies support the use of the plant-derived flavonoid apigenin as a potential nutraceutical for preventing a number of different cancers. However the effect of dietary apigenin on prevention of progestin-accelerated breast tumors has hitherto not been explored. Medroxyprogesterone acetate (MPA) is the most commonly used synthetic progestin administered to post-menopausal women for hormone replacement therapy. MPA accelerates the development of breast cancers by reducing tumor latency and increasing tumor incidence and multiplicity in a DMBA-induced breast cancer model, and causes progression of human cancer cells in xenografts (Clin Can Res, 2006, 12:4062; Cancer Res, 2007, 67: 9929). Previously we showed that intraperitoneally administered apigenin effectively treated and prevented the progression of MPA-accelerated breast cancer in both the DMBA-induced, and xenograft mammary cancer models (Cancer Prev Res, 2011, 4: 1316; Horm Canc, 2012, 3: 160). In the present study we used the DMBA model to examine the chemopreventive effect of dietary apigenin against MPA-accelerated tumors. Based on reports in the literature, we examined the effects of feeding 3 different dietary levels of apigenin (0.02%, 0.1% and 0.5% wt/wt) in a phytoestrogen-free diet following treatment with DMBA, and prior to implantation of MPA pellets which accelerate tumor development. The MPA-dependent tumor incidence was lower in the 0.1% dietary apigenin treatment group. Surprisingly, the same dietary level significantly increased tumor multiplicity in those animals that developed tumors. A five-fold increase (0.5%) or reduction (0.02%) in dietary apigenin failed to reduce MPA-dependent tumor incidence and the higher dose (0.5%) substantially increased tumor multiplicity compared with MPA alone. Tumor incidence and multiplicity were unaffected in apigenin-fed animals that were treated with DMBA but supplemented with placebo pellets. There were no morphological or histological differences between tumors from animals fed apigenin-supplemented diets and those given a control diet, either in the presence or absence of MPA.These findings show that apigenin, given in a diet devoid of phytochemicals, exacerbated the effects of MPA on tumor development and multiplicity in a chemically-induced breast cancer model. Consequently, until further research clarifies the effect of dietary apigenin on progestin-accelerated tumors, caution should be exercised when considering the flavonoid as a dietary supplement for preventing hormone-dependent breast cancer. Supported by a COR award from University of Missouri, and research funds from RADIL.

Citation Format: Benford Mafuvadze, Matthew Cook, Xu Zhang, Cindy Besch-Williford, Salman M. Hyder. Complex effects of dietary apigenin on prevention of MPA-accelerated DMBA-induced mammary tumors in Sprague-Dawley rats. [abstract]. In: Proceedings of the 104th Annual Meeting of the American Association for Cancer Research; 2013 Apr 6-10; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2013;73(8 Suppl):Abstract nr 3694. doi:10.1158/1538-7445.AM2013-3694

  • ©2013 American Association for Cancer Research
Back to top
Cancer Research: 73 (8 Supplement)
April 2013
Volume 73, Issue 8 Supplement
  • Table of Contents
  • Index by Author

Sign up for alerts

Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Research article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Abstract 3694: Complex effects of dietary apigenin on prevention of MPA-accelerated DMBA-induced mammary tumors in Sprague-Dawley rats.
(Your Name) has forwarded a page to you from Cancer Research
(Your Name) thought you would be interested in this article in Cancer Research.
Citation Tools
Abstract 3694: Complex effects of dietary apigenin on prevention of MPA-accelerated DMBA-induced mammary tumors in Sprague-Dawley rats.
Benford Mafuvadze, Matthew Cook, Xu Zhang, Cindy Besch-Williford and Salman M. Hyder
Cancer Res April 15 2013 (73) (8 Supplement) 3694; DOI: 10.1158/1538-7445.AM2013-3694

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Abstract 3694: Complex effects of dietary apigenin on prevention of MPA-accelerated DMBA-induced mammary tumors in Sprague-Dawley rats.
Benford Mafuvadze, Matthew Cook, Xu Zhang, Cindy Besch-Williford and Salman M. Hyder
Cancer Res April 15 2013 (73) (8 Supplement) 3694; DOI: 10.1158/1538-7445.AM2013-3694
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
Advertisement

Related Articles

Cited By...

More in this TOC Section

Prevention Research

  • Abstract LB-153: Lotus leaf and Cassia seed extracts, through activating Nrf2 pathway, suppress TPA-induced mouse skin cell transformation
  • Abstract LB-174: Patient navigation in Appalachia: results from a survey of current practices
  • Abstract LB-167: A novel metabolite of citrus tangeretin epigenetically inhibits the growth of human prostate cancer cells
Show more 3

Poster Presentations - Proffered Abstracts

  • Abstract LB-153: Lotus leaf and Cassia seed extracts, through activating Nrf2 pathway, suppress TPA-induced mouse skin cell transformation
  • Abstract LB-174: Patient navigation in Appalachia: results from a survey of current practices
  • Abstract LB-167: A novel metabolite of citrus tangeretin epigenetically inhibits the growth of human prostate cancer cells
Show more 3

Poster Presentations - Preclinical Animal Models 2

  • Abstract 3690: p53 stabilizing agent CP-31398 prevents urinary bladder tumor growth and invasion in transgenic UPII-SV40T mice.
  • Abstract 3710: Targeted inhibition of arginase-1 may underline the suppression of the development of colonic neoplasia in a transgenic APC Min mouse model.
  • Abstract 3697: Molecular link that associates high fat diet and prostate tumor growth.
Show more 3
  • Home
  • Alerts
  • Feedback
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians
  • Reviewers

About Cancer Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2018 by the American Association for Cancer Research.

Cancer Research Online ISSN: 1538-7445
Cancer Research Print ISSN: 0008-5472
Journal of Cancer Research ISSN: 0099-7013
American Journal of Cancer ISSN: 0099-7374

Advertisement